acromegaly

LUND, Sweden, July 17, 2026 Camurus announced that the U.S. Food and Drug Administration (FDA) has accepted for review...

SOUTH SAN FRANCISCO, Calif., May 26, 2026 Marea Therapeutics announced that new data from its first-in-human Phase 1 clinical...

San Diego, USA – March 26, 2026 Crinetics Pharmaceuticals announced the submission of a Marketing Authorization Application (MAA) to...

SAN DIEGO, Sept. 25, 2025 — The U.S. Food and Drug Administration (FDA) has approved PALSONIFY™ (paltusotine) as the...

Lund, Sweden — August 28, 2025 — The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval...